Santen Pharmaceutical Co., Ltd. ( SNPHY) - Stock Earnings
SNPHY Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 51.2 million USD | 473.6 million USD |
| 2026Q1 | 99.1 million USD | 515.5 million USD |
| 2026Q2 | 44.8 million USD | 429.6 million USD |
SNPHY Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | 176.0 million USD | 2.0 billion USD |
| 2025 | 242.7 million USD | 2.0 billion USD |
| 2026 | 248.1 million USD | 1.9 billion USD |
| 2026 Est. | — | — |
SNPHY
Price: $11.82
52 week price:
Dividend Yield: 1.81%
Earnings Per Share: 0.73 USD
P/E Ratio: 15.19
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 3.4 billion